Jen Nwankwo, CEO of 1910 Genetics, sits down with Amar Drawid to discuss her company’s approach to AI drug discovery, how it is seeking to address big challenges that plague the industry, and why the company is agnostic to drug modality. 

In this episode Tuvik Beker, CEO of Pangea Biomed, sits down with Dr. Amar Drawid to discuss the evolution of precision medicine, the challenges in matching the right drugs to the right patient, and how Pangea uses AI to analyze expression data and gene interaction maps to select the most effective drugs for individual patients.

Data analytics has evolved significantly in the pharmaceutical industry, providing sales professionals with better insights and decision-making capabilities. On this episode, Dr. Amar Drawid sits down with 40-year biopharmaceutical industry veteran Jonathan Blutfield, principal consultant with TriRadial Solutions, to discuss the evolution of data analytics for commercial teams, how sales reps play a vital role in personalizing interactions with healthcare professionals, and how companies can enhance the effectiveness of data analytics tools and integrate them into their sales strategies.